Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Electrospun scaffolds can improve healing in diabetic wounds.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

New treatments for skin and hair repair show promise, but further improvements are needed.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Applying a specific inhibitor lightens skin and hair color.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Certain substances that block a specific protein help promote hair growth.

Foxn1 helps skin cells mature by controlling a specific protein's activity.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.